Selenium: As A Diagnostic Marker For Malignant Neoplasm

摘要: The deficiency of selenium has been correlated with the accelerated development prostrate cancer in transgenic mice whereas supplementary found to reduce progression lungs human. This study aims at exploring any association or otherwise blood level patient occurrence and investigation as a biomarker for malignancy. 368 samples were collected including healthy patients. Results shows that concentration levels 16 70 years males females both combined together weighted averages control group are 0.121± 0.03 µg per ml (n= 170). Besides breast patients fall range 0.057 ± 0.017 119) 0.056± 0.018 198) respectively. In significantly lower than P> 0.05 critical value > 0.009 0.01 Studies also revealed there is sharp decline irrespective gender, age, type compared controls.